Thrive Bioscience Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Later Stage VC
- Investors
-
29
Thrive Bioscience General Information
Description
Developer of a science-based analytical and automation technology designed to offer data, imaging, analytics, and automation for live cell biology. The company provides automated, extensive, and comparable images and data sets on live cells and tissues that are needed for insights, it is also developing and delivering software modules for key drug discovery workflows that use machine learning to improve experimental assays and research insights, providing medical professionals to improve cell culture and stem cell culture processes.
Contact Information
Website
www.thrivebio.comCorporate Office
- 100 Cummings Center
- Suite 407-P
- Beverly, MA 01915
- United States
Corporate Office
- 100 Cummings Center
- Suite 407-P
- Beverly, MA 01915
- United States
Thrive Bioscience Timeline
Thrive Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | Completed | Generating Revenue | ||||
| 10. Later Stage VC (Series B) | Completed | Generating Revenue | ||||
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Later Stage VC | 30-Jul-2022 | Completed | Generating Revenue | |||
| 7. Debt - PPP | 01-Feb-2021 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 01-Sep-2020 | Completed | Generating Revenue | |||
| 5. Debt - PPP | 30-Apr-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A) | 06-Mar-2017 | Completed | Generating Revenue | |||
| 3. Debt - General | 01-Jul-2016 | $1M | $5M | Completed | Generating Revenue | |
| 2. Seed Round | 30-Apr-2015 | $4M | $4M | Completed | Product Development |
Thrive Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Thrive Bioscience Comparisons
Industry
Financing
Details
Thrive Bioscience Competitors (34)
One of Thrive Bioscience’s 34 competitors is Cellino, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cellino | Venture Capital-Backed | Cambridge, MA | ||||
| Stemnovate | Venture Capital-Backed | Cambridge, United Kingdom | ||||
| TissUse | Accelerator/Incubator Backed | Berlin, Germany | ||||
| Echo (Devices and Supplies) | Venture Capital-Backed | San Diego, CA | ||||
| Xcell Biosciences | Venture Capital-Backed | San Francisco, CA |
Thrive Bioscience Patents
Thrive Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240412371-A1 | Method and apparatus for searching and analyzing cell images | Pending | 06-Oct-2021 | ||
| US-20240288677-A1 | Method and apparatus for calibrating an imaging system | Pending | 27-Sep-2021 | ||
| US-20240309310-A1 | Plaque detection method and apparatus for imaging of cells | Pending | 02-Jul-2021 | ||
| US-20240209304-A1 | Device, method and apparatus for controlling humidity in an incubator | Pending | 26-Apr-2021 | ||
| US-20240185422-A1 | Plaque detection method and apparatus for imaging of cells | Pending | 19-Apr-2021 | G06T7/0016 |
Thrive Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Thrive Bioscience Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Douglas Hansen | Angel (individual) | Minority | ||
| Intelligent Machines Ventures | Venture Capital | Minority | ||
| Ogden CAP Associates | Venture Capital | Minority | ||
| Agility Labs | Accelerator/Incubator | Minority | ||
| Ankur Patel | Angel (individual) | Minority |
Thrive Bioscience FAQs
-
When was Thrive Bioscience founded?
Thrive Bioscience was founded in 2014.
-
Where is Thrive Bioscience headquartered?
Thrive Bioscience is headquartered in Beverly, MA.
-
What is the size of Thrive Bioscience?
Thrive Bioscience has 40 total employees.
-
What industry is Thrive Bioscience in?
Thrive Bioscience’s primary industry is Other Healthcare Technology Systems.
-
Is Thrive Bioscience a private or public company?
Thrive Bioscience is a Private company.
-
What is Thrive Bioscience’s current revenue?
The current revenue for Thrive Bioscience is .
-
How much funding has Thrive Bioscience raised over time?
Thrive Bioscience has raised $38.6M.
-
Who are Thrive Bioscience’s investors?
Douglas Hansen, Intelligent Machines Ventures, Ogden CAP Associates, Agility Labs, and Ankur Patel are 5 of 29 investors who have invested in Thrive Bioscience.
-
Who are Thrive Bioscience’s competitors?
Cellino, Stemnovate, TissUse, Echo (Devices and Supplies), and Xcell Biosciences are some of the 34 competitors of Thrive Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
